glp-1 and ketosis Ketosis: Novel Mental Health Treatments Bozmd Does GLP-1 Block Autophagy?
Description
Start your healthier future - book a free consult today.
GLP-1 Studio is an advocacy media production platform focused on GLP-1 education, access, and self-advocacy
Care that fits you
In this report, we describe the case of a 55yearold woman with a history of chronic kidney disease, diabetes mellitus type 2 with neuropathy, peripheral vascular disease, and prior pancreatitis, who presented with severe gastrointestinal symptoms, sepsis physiology, and evidence of metabolic derangement shortly after uptitration of tirzepatide therapy, consistent with the established temporal relationship of GLP-1 dose titration and gastrointestinal side effects
Prior to this, she reported doing well aside from worsening reflux and 1 episode of emesis
Postprandial active GLP-1 was increased at 5% WL (P<0.01) and CCK reduced at 5 and 10% WL (P<0.01, for both) and wk 9 (P<0.001)
